Drawing for AARDEX

USPTO serial 79252543

AARDEX

Reviewed by CopyMark Law Group

Reg. 5929373Status 739Registered
Filing date
Status date
Registration date
Dec 10, 2019
Examiner
MACFARLANE, JAMES W
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with AARDEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi, Esq.

Christina M. Licursi, Esq. Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments, namely, electronic analyzers and physical and chemical laboratory apparatus and instruments used for drug detection and the analysis of body fluids for scientific purposes; apparatus for information recording and processing; measuring, control and inspection apparatus and instruments, for scientific use, namely, gauges for measuring drug concentration levels for scientific purposes; blank digital recording storage media; data processing equipment, namely, data processors; apparatus for recording, transmitting, processing and reproducing data; apparatus for processing, transmission and storage of database information, namely, computers; apparatus for recording time and the date, namely, computers; software applications for use on mobile devices for use in data processing and database management in the fields of pharmaceuticals and biotechnology; downloadable applications for mobile devices for use in data processing and database management in the fields of pharmaceuticals and biotechnology; computer memory devices for use with data processing apparatus; LCD display screens; electronic data recorders; software for use in data processing and database management in the fields of pharmaceuticals and biotechnology; compiling software; database management software; downloadable electronic publications, namely, manuals featuring pharmaceutical and biotechnology content recorded on computer media; data processing systems, namely, data processors; downloadable cloud computing software for use in data processing and database management in the fields of pharmaceuticals and biotechnologyACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, medical devices for use in drug detection and the analysis of body fluids; walkers for disabled personsACTIVE—
042Scientific and technological services, as well as research and design relating thereto, namely, research and development of technology in the fields of pharmaceuticals and biotechnology; design and development of software; scientific assessments, estimates, research and reporting, namely, conducting scientific research in the fields of pharmaceuticals and biotechnology; engineering services and design and advisory services with respect to information technologies concerning the securing of computer data and personal and financial information and concerning the detection of unauthorized access to data and information; scientific research services in the medical field; design, development, rental and programming of operating software for accessing as well as using a cloud computing network; digital compression of computer data; design of data processing apparatus; computer database design; design, development, maintenance and updating of data processing software; design and development of medical technologies; development of data processing software; quality evaluation of pharmaceutical products; pharmaceutical research and development servicesACTIVE—
044Medical services; medical analysis services in the framework of treating individuals; pharmacy consultancy services, namely, pharmaceutical consultation; medical analysis services in the framework of the treatment of persons provided by medical laboratories; medical care and analysis services in the framework of patient treatment; medical assessment services concerning the taking of pharmaceuticals in the framework of patient follow-upsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 12, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 17, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 10, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 10, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 25, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 25, 2020FIMPFINAL DISPOSITION PROCESSED—
Mar 10, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2019GPNXNOTIFICATION PROCESSED BY IB—
Sep 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 29, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2019RFNTREFUSAL PROCESSED BY IB—
Jun 29, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 29, 2019RFRRREFUSAL PROCESSED BY MPU—
Jun 13, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2019RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Apr 29, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 28, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2019RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Mar 17, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2019DOCKASSIGNED TO EXAMINER—
Mar 5, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 27, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance